Michael R. Rodriguez

Endocare, Inc. is a medical device manufacturer of cryoablation technologies for treating cancerous tissue and tumors. The company was founded in 1996 and is headquartered in Austin, TX.

Tickets.com, Inc. provides ticketing solutions for live events. Its products include tickets phone & home, private label, mytickets, fund development and event ticket insurance. The company was founded in 1995 and is headquartered in Costa Mesa, CA.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Directfit, Inc. provided Web-centric IT professional search and staffing services. The company is headquartered in Irvine, CA.

Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.

Crossover Health, Inc. provides worksite health and wellness services. It offers primary, ancillary, and advanced services, includes urgent care, occupational health, preventive care, chronic disease management, health risk assessment, health education, health coaching, biometrics, physical therapy, chiropractic, acupuncture, specialist preferred network, care coordination, health analytics, and remote care. The company was founded by Scott Shreeve in 2010 and is headquartered in Aliso Viejo, CA.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.